Projects funded by the NCN
Enhancement of antidepressant therapy by combined administration of hyperforin and ketamine: behavioral and molecular studies
2021/43/D/NZ7/02635
Keywords:
ketamine r-ketamine,s-ketamine hyperforin depression NMDA
Descriptors:
- NZ7_14: Pharmacy, pharmacotherapy, pharmacology
Panel:
NZ7 - Diagnostic tools, therapies and public health: public health, epidemiology, environmental health risks and occupational medicine, medical ethics, drug discovery and therapies, pharmacology
Host institution :
Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk
woj. małopolskie
Principal investigator (from the host institution):
Number of co-investigators in the project: 6
Call: SONATA 17 - announced on 2021-09-15
Amount awarded: 925 640 PLN
Project start date (Y-m-d): 2022-07-11
Project end date (Y-m-d): 2025-07-10
Project duration:: 36 months (the same as in the proposal)
Project status: Pending project
Project description
Download the project description in a pdf file
Note - project descriptions were prepared by the authors of the applications themselves and placed in the system in an unchanged form.